ARMISTICE CAPITAL, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Dermata Therapeutics, Inc. Common Stock, par value $0.0001 per share (DRMA)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Dermata Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: DRMA
Shares outstanding: 1,080,361 shares
Disclosed Ownership: 53,910 shares
Ownership: 5%
Form type: SCHEDULE 13G/A
Filing time: 17 Feb 2026, 21:48:09 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	5%	53,910	0	53,910	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	5%	53,910	0	53,910	/s/ Steven Boyd	Steven Boyd